🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
This research study is studying an investigational drug, NC318, as a possib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-06
Trial ID
NCT04430933
Treatments Being Tested
This Phase II, multicenter, randomized trial is designed to make preliminar...
Status
Completed
Location
Comprehensive Blood and Cancer Center (TORI)
Start Date
2004-07
Trial ID
NCT00095225
Treatments Being Tested
This study is designed to compare the efficacy and safety of first-line ico...
Status
Unknown
Location
Chinese People's Liberation Army (PLA) General Hospital
Start Date
2012-08
Trial ID
NCT01665417
Treatments Being Tested
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2007-10
Trial ID
NCT00520845
Treatments Being Tested
This phase II randomised, double blind, placebo controlled, multicentre tri...
Status
Unknown
Location
Hunan Province Tumor Hospital
Start Date
2012-09
Trial ID
NCT01707329
Treatments Being Tested
This study evaluated the effectiveness and safety of Camrelizumab combinati...
Status
Unknown
Location
Sichuan Cancer Hospital & Institute
Start Date
2021-12-21
Trial ID
NCT05472467
Treatments Being Tested
This is a prospective, multicenter, randomized, uncontrolled Phase II study...
Status
Recruiting
Location
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2024-09-24
Trial ID
NCT06775275
Treatments Being Tested
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested